·
EDITORIAL
·
Celebrating the 2nd anniversary of Biomaterials Translational
Show Less
1
Institute of Life Science, Swansea University Medical School, Swansea,
UK
2
Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC,
USA
BMT 2022 , 3(4), 235–236;
https://doi.org/10.12336/biomatertransl.2022.04.002
Submitted: 29 December 2022 | Published: 28 December 2022
Copyright © 2022 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution–NonCommercial–ShareAlike 4.0 License.
References
Below is the content of the Citations in the paper which has been de-formatted, however, the content stays consistent with the original.
- Giusto, E.; Blunn, G.; de Godoy, R.; Liu, C.; Pendegrass, C. Optimising soft tissue in-growth in vivo in additive layer manufactured osseointegrated transcutaneous implants. Biomater Transl. 2022, 3, 243-249.
- 2. Fan, J.; Pung, E.; Lin, Y.; Wang, Q. Recent development of hydrogen sulfide-releasing biomaterials as novel therapies: a narrative review. Biomater Transl. 2022, 3, 250-263.
- 3. Wang, Y.; Chen, Y.; Wei, Y. Osteoarthritis animal models for biomaterial-assisted osteochondral regeneration. Biomater Transl. 2022, 3, 264-279.
- 4. Yuan, G.; Li, Z.; Lin, X.; Li, N.; Xu, R. New perspective of skeletal stem cells. Biomater Transl. 2022, 3, 280-294.
- 5. Xia, Z. Skeletal interoception: an emerging area for musculoskeletal research. Biomater Transl. 2022, 3, 237-239.
- 6. Guo, H.; Huang, X. Engineered exosomes for future gene-editing therapy. Biomater Transl. 2022, 3, 240-242.
Conflict of interest
The authors declare they have no competing interests.
